ETON Eton Pharmaceuticals Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ETON

Price (delayed)

$55.61

Market cap

$1.59B

P/E Ratio

118.32

Dividend/share

N/A

EPS

$0.47

Enterprise value

$1.59B

?
Relative Growth: Rel. Growth: 98
Relative Strength: Rel. Strength: 98
Relative Valuation: Rel. Valuation: 29
Relative Profitability: Rel. Profitability: 97
Highlights
ETON's equity has surged by 94% year-on-year and by 52% since the previous quarter
The revenue has soared by 78% YoY and by 21% QoQ
The gross margin has grown by 6% from the previous quarter but it has contracted by 3.8% YoY
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: http://www.etonpharma.com
Peers: OPK ORGO

Key stats

What are the main financial stats of ETON

ETON stock price

How has the Eton Pharmaceuticals stock price performed over time
Intraday
-2.59%
1 week
-1.31%
1 month
-12.38%
1 year
180.43%
YTD
228.86%
QTD
53.62%

Financial performance

How have Eton Pharmaceuticals's revenue and profit performed over time
Revenue
$105.6M
Gross profit
$61.1M
Operating income
$16.31M
Net income
$12.69M
Gross margin
57.9%
Net margin
12%
The revenue has soared by 78% YoY and by 21% QoQ
Eton Pharmaceuticals's gross profit has soared by 71% YoY and by 28% from the previous quarter
The gross margin has grown by 6% from the previous quarter but it has contracted by 3.8% YoY

Price vs fundamentals

How does ETON's price correlate with its fundamentals

Growth

What is Eton Pharmaceuticals's growth rate over time

Valuation

What is Eton Pharmaceuticals stock price valuation
P/E
118.32
P/B
32.7
P/S
14.56
EV/EBIT
97.59
EV/EBITDA
76.12
EV/Sales
15.07
ETON's equity has surged by 94% year-on-year and by 52% since the previous quarter
The stock's price to book (P/B) is 56% more than its last 4 quarters average of 21.5
ETON's P/S is 177% above its 5-year quarterly average of 5.4 and 92% above its last 4 quarters average of 7.8
The revenue has soared by 78% YoY and by 21% QoQ

Efficiency

How efficient is Eton Pharmaceuticals business performance

Dividends

What is ETON's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ETON.

Financial health

How did Eton Pharmaceuticals financials performed over time
ETON's total assets is 67% more than its total liabilities
The quick ratio has soared by 53% from the previous quarter and by 12% YoY
Eton Pharmaceuticals's current ratio has increased by 26% from the previous quarter but it has decreased by 14% YoY
The debt is 38% smaller than the equity
ETON's equity has surged by 94% year-on-year and by 52% since the previous quarter
ETON's debt to equity has dropped by 52% year-on-year and by 39% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.